Walleye Capital LLC Aravive, Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.85 - $2.75 $68,425 - $101,714
-36,987 Closed
0 $0
Q4 2021

Mar 03, 2022
SELL
$2.19 - $4.07 $39,634 - $73,658
-18,098 Reduced 32.85%
36,987 $0
Q3 2021

Nov 15, 2021
BUY
$3.67 - $5.8 $85,092 - $134,478
23,186 Added 72.69%
55,085 $205,000
Q2 2021

Aug 16, 2021
BUY
$4.65 - $6.42 $148,330 - $204,791
31,899 New
31,899 $191,000

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email